DGF knows nothing about running a cannabis pharma company. Everyone that had anything to do with this company is gone. The inexperienced ownership makes 99.9% of the decisions, the investors make .001%. The only approved market is Israel for the cream, and that is whenever they figure out how to package and deliver a product. Companies are already out with tablets-and there are YEARS ahead for any US approvals for any product. Yep, a great investment. Maybe all the AP*PL investors should sell their holdings and come here.
DGF isn't going to build a business that isn't what toxic lenders do - they dump shares at any price since they are floorless - now DGF has 821 Billion shares - it is obvious what they are going to do - and DGF controls the vote so they can do anything they want such as a reverse split.
Market Data 
Markets 
AI
